06855.HK
Ascentage Pharma Group International Co., Ltd.
HKSE · Healthcare · Biotechnology · CN
HKD 27.20
−3.61%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 10.98x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 14.81x
- Price / sales
- 13.02x
- Price / cash flow
- -5.97x
Enterprise value
- Enterprise value
- HKD 9.9B
- EV / sales
- 13.35x
- EV / EBITDA
- -6.50x
- EV / EBIT
- -6.10x
- Market cap
- HKD 9.7B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026